Second-line treatment of non-small cell lung cancer: Big targets, small progress; Small targets, big progress?

被引:7
|
作者
Hanna, Nasser [1 ]
机构
[1] Indiana Univ, Dept Med, Bloomington, IN 47405 USA
关键词
D O I
10.1097/01243894-200611000-00001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:927 / 928
页数:2
相关论文
共 50 条
  • [1] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [2] Second-line chemotherapy for non-small cell lung cancer
    Ruckdeschel, JC
    [J]. CHEST, 2006, 129 (04) : 840 - 842
  • [3] Second-line chemotherapy for non-small cell lung cancer
    De Marinis, F.
    De Santis, S.
    De Petris, L.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V68 - V71
  • [4] Non-small cell lung cancer: second-line and beyond
    Stahel, R. A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : X97 - X100
  • [5] Single agents in the second-line treatment of non-small cell lung cancer
    Belani, CP
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (03) : 10 - 14
  • [6] Geographic variation in the second-line treatment of non-small cell lung cancer
    Edelman, MJ
    Sekine, I
    Tamura, T
    Saijo, N
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S39 - S44
  • [7] An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer
    Scagliotti, G
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2855 - 2866
  • [8] Second-line treatment options in advanced non-small cell lung cancer
    de Marinis, Filippo
    Ricciardi, Serena
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S258 - S271
  • [9] Future directions in the second-line treatment of non-small cell lung cancer
    Rosell, R
    Cecere, F
    Cognetti, F
    Cuello, M
    Sanchez, JM
    Taron, M
    Reguart, N
    Jablons, D
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S45 - S51
  • [10] Docetaxel and carboplatin as the second-line treatment of non-small cell lung cancer
    Pesek, M
    Holá, V
    [J]. LUNG CANCER: CURRENT TOPICS, 2001, : 155 - 160